Literature DB >> 7545102

Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture.

K Kasai1, Y Hattori, N Nakanishi, K Manaka, N Banba, S Motohashi, S Shimoda.   

Abstract

We now report on the induction and modulation of NO production by cytokines in primary cultures of human thyrocytes and the effect of NO on iodine organification by human open thyroid follicles in the process of thyroid hormone biosynthesis. Although unstimulated thyrocytes produced little NO (measured as nitrite), interleukin-1 alpha or beta (IL-1 alpha/beta) substantially increased NO formation. Interferon-gamma (IFN-gamma) by itself failed to stimulate NO formation but markedly increased the IL-1-stimulated NO production. Tumor necrosis factor-alpha alone did not induce NO production but did so slightly in the presence of IFN-gamma. Induction of NO formation by thyrocytes upon stimulation with IL-1 alpha + IFN-gamma was accompanied by the synthesis of tetrahydrobiopterin (BH4), an obligatory cofactor of NOS. Coinduction of NO and BH4 synthesis in thyrocytes was preceded by coexpression of messenger RNAs for NOS and GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme for de novo synthesis of BH4. NO synthesis was prevented by an inhibitor of GTPCH, 2,4-diamino-6-hydroxypyrimidine, and this inhibition was completely reversed by administration of sepiapterin, a substrate for BH4 synthesis via pterin salvage pathway. In contrast to IFN-gamma, some cytokines such as interferon-alpha, IL-4, and transforming growth factor-beta 1 inhibited the IL-1-induced NO production. Finally, a possible role of NO on thyroid hormone synthesis was investigated. Iodine organification by human open thyroid follicles was inhibited by two kinds of NO donor but not by cell permeable cyclicGMP analog. Thus, cytokines such as IL-1, IL-1/IFN-gamma, and tumor necrosis factor-alpha/IFN-gamma stimulate human thyrocytes to produce NO; this process can be modulated by other cytokines and coregulated with a cofactor BH4 biosynthesis, and resulting NO may affect cell function including thyroid hormone synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545102     DOI: 10.1210/endo.136.10.7545102

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro.

Authors:  Sylvie Poncin; Ides M Colin; Brigitte Decallonne; Isabelle Clinckspooor; Marie-Christine Many; Jean-François Denef; Anne-Catherine Gérard
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 2.  Cytokines in immune function and sleep regulation.

Authors:  James M Krueger; Jeannine A Majde; David M Rector
Journal:  Handb Clin Neurol       Date:  2011

3.  Staphylococcal enterotoxin A-induced fever is associated with increased circulating levels of cytokines in rabbits.

Authors:  W T Huang; M T Lin; S J Won
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Quercetin suppresses proinflammatory cytokines production through MAP kinases andNF-kappaB pathway in lipopolysaccharide-stimulated macrophage.

Authors:  Sung-Yeon Cho; Sang-Joon Park; Myung-Ja Kwon; Tae-Sook Jeong; Song-Hae Bok; Woo-Young Choi; Won-Il Jeong; Si-Yun Ryu; Sun-Hee Do; Cha-Soo Lee; Jae-Chan Song; Kyu-Shik Jeong
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

5.  Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.

Authors:  A Patel; C Fenton; R Terrell; P A Powers; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

6.  The changes of the thyroid function and serum testosterone levels after long-term L-NAME treatment in male rats.

Authors:  M Haluzík; J Nedvídková; V Kopský; J Jahodová; B Horejsí; V Schreiber
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.